Target intelligence / Profile preview

Cullin-associated NEDD8-dissociated protein 1 (CAND1)

Target
CAND1
Molecular classification
Other (E3 ubiquitin ligase regulator)
01

Overview

Cullin-associated NEDD8-dissociated protein 1 (CAND1) is an essential regulator of cullin-RING ubiquitin ligases (CRLs), particularly the SCF (Skp1–Cullin1–F-box protein) E3 ligase complexes responsible for targeted protein ubiquitination and proteasomal degradation. CAND1 acts as a "substrate receptor exchange factor," binding to unneddylated cullin scaffolds and displacing the Skp1–F-box protein complex, thereby recycling the cullin scaffold and allowing exchange for new F-box substrate receptors. This process is critical for protein homeostasis, timely cell cycle progression, and cellular adaptation to changing substrate pools. CAND1 dysfunction impairs proteostasis, leading to defective development, increased cell death in certain contexts, and is linked to various human diseases including cancer, metabolic, and cardiovascular disorders. No direct therapeutic drugs target CAND1, but its modulation is being explored for disease treatment and its altered expression is associated with several pathological states.

Other names
Cullin-associated NEDD8-dissociated protein 1CAND1KIAA0829TIP120TIP120ATBP-interacting protein 120ADKFZp434M1414p120 CAND1
02

Biological functions

Regulation of protein ubiquitination and degradationSCF (Skp1–Cullin–F-box) E3 ligase complex assembly and exchangeProtein homeostasisCell cycle regulationDevelopmental processes
03

Disease associations

Cancer (e.g., prostate cancer, lung cancer)Metabolic diseases (e.g., nonalcoholic fatty liver disease, adipogenesis defects)Cardiovascular disease (e.g., heart failure)Developmental disorders (e.g., viability, organ development in model organisms)
04

Safety considerations

Essential for cell viability in systems with large F-box protein pools (potential lethality if knocked out)Broad impact on protein degradation pathways—implicated in multiple disease processes

Beyond the preview

Go deeper on Cullin-associated NEDD8-dissociated protein 1 (CAND1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cullin-associated NEDD8-dissociated protein 1 (CAND1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call